Incannex Healthcare (IXHL) Competitors

MetaVia (NASDAQ:MTVA) and Incannex Healthcare (NASDAQ:IXHL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, community ranking, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

Is MTVA or IXHL more profitable?

MetaVia's return on equity of -189.12% beat Incannex Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MetaVia	N/A	-189.12%	-122.31%
Incannex Healthcare	N/A	-289.30%	-154.96%

Do institutionals and insiders hold more shares of MTVA or IXHL?

1.4% of MetaVia shares are owned by institutional investors. Comparatively, 0.4% of Incannex Healthcare shares are owned by institutional investors. 1.1% of MetaVia shares are owned by company insiders. Comparatively, 26.5% of Incannex Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has more volatility and risk, MTVA or IXHL?

MetaVia has a beta of 0.21, meaning that its stock price is 79% less volatile than the S&P 500. Comparatively, Incannex Healthcare has a beta of 7.67, meaning that its stock price is 667% more volatile than the S&P 500.

Does the MarketBeat Community believe in MTVA or IXHL?

MetaVia received 4 more outperform votes than Incannex Healthcare when rated by MarketBeat users.

Company	Underperform	Outperform
MetaVia	Outperform Votes 4 100.00%	Underperform Votes No Votes
Incannex Healthcare	N/A	N/A

Do analysts prefer MTVA or IXHL?

MetaVia presently has a consensus price target of $7.50, indicating a potential upside of 799.50%. Given MetaVia's stronger consensus rating and higher probable upside, research analysts plainly believe MetaVia is more favorable than Incannex Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MetaVia	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Incannex Healthcare	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has better earnings and valuation, MTVA or IXHL?

MetaVia has higher earnings, but lower revenue than Incannex Healthcare.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MetaVia	N/A	N/A	-$12.47M	N/A	N/A
Incannex Healthcare	$98K	41.19	-$18.46M	-$1.21	-0.19

Does the media favor MTVA or IXHL?

In the previous week, Incannex Healthcare had 4 more articles in the media than MetaVia. MarketBeat recorded 9 mentions for Incannex Healthcare and 5 mentions for MetaVia. MetaVia's average media sentiment score of 0.50 beat Incannex Healthcare's score of 0.32 indicating that MetaVia is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MetaVia	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Incannex Healthcare	0 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

MetaVia beats Incannex Healthcare on 9 of the 13 factors compared between the two stocks.